Summit Therapeutics Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2019 | $17.4M | $96.2M | $35.2M |
| FY2020 | $23.0M | $102.5M | $66.4M |
| FY2021 | $30.1M | $113.4M | $71.8M |
| FY2022 | $537.5M | $664.2M | $348.6M |
| FY2023 | $125.3M | $202.9M | $71.4M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2019 | $17.4M | $96.2M | $35.2M |
| FY2020 | $23.0M | $102.5M | $66.4M |
| FY2021 | $30.1M | $113.4M | $71.8M |
| FY2022 | $537.5M | $664.2M | $348.6M |
| FY2023 | $125.3M | $202.9M | $71.4M |